SpringerLink
Log in

Effect of long-term administration of ranitidine, a histamine H2 receptor antagonist, on bone metabolism in young growing rats

  • Original article
  • Published:
Pharmacological Reports Aims and scope Submit manuscript

Abstract

Background

Histamine regulates function of osteoclasts and osteoblasts, however data regarding the influence of histamine H2 receptors antagonists on bone tissue are ambiguous. Factors that influence growing skeleton may have an important impact on the peak bone mass and future risk of fractures. The aim of our study was the assessment of influence of ranitidine, on growing bones.

Methods

The experiment was carried out on young male Wistar rats divided into two groups receiving either ranitidine (10 mg/kg ip) or vehicle.

Results

A significant decrease in femoral BMD in ranitidine-treated rats (R) compared to vehicle-treated ones (C) was detected (0.262 ± 0.009 g/cm2vs. 0.271 ±0.007 g/cm2, p < 0.05). In group R we observed elevated serum C-terminated telopeptide of type I collagen (CTX) level with concomitantly lowered serum osteocalcin (OC) concentration comparing to control group (151.2 ± 27.2 pg/ml vs. 101.5 ± 55.6, p < 0.05 and 229.1 ± 50.0 pg/ml vs. 292.0 ± 52.9, p < 0.05, respectively). Serum concentration of inorganic phosphorus was lower in group R than in group C (134 ± 13 mmol/L vs. 157 ± 28 mmol/L, p < 0.05).

Conclusions

Long-term administration of ranitidine increases bone resorption and decreases bone formation in growing rats leading to decrease in BMD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 1994;843:1–129.

    Google Scholar 

  2. Johnell O. The Socioeconomic Burden of Fractures: today and in the 21 st Century. Am J Med 1997;103:20S–5S, doi:https://doi.org/10.1016/S0002-9343(97)90023-1.

    Article  CAS  Google Scholar 

  3. Ikawa Y, Yonekawa T, Ohkuni Y, Kuribayashi M, Fukino K, Ueno K. A comparative study of histamine activities on differentiation of osteoblasts and osteoclasts. J Toxicol Sci 2007;32:555–64, doi:https://doi.org/10.2131/jts.32.555.

    Article  CAS  Google Scholar 

  4. Longhini R, de Oliveira PA, de Souza Faloni AP, Sasso-Cerri E, Cerri PS. Increased apoptosis in osteoclasts and decreased RANKL immunoexpression in periodontium of cimetidine-treated rats. J Anat 2013;222:239–47, doi:https://doi.org/10.1111/joa.12011.

    Article  CAS  Google Scholar 

  5. Deyama Y, Kikuiri T, Ohnishi GI, Feng YG, Takeyama S, Hatta M, et al. Histamine stimulates production of osteoclast differentiation factor/receptor activator of nuclear factor-kappaB ligand by osteoblasts. Biochem Biophys Res Commun 2002;298:240–6, doi:https://doi.org/10.1016/S0006-291X(02)02440-3.

    Article  CAS  Google Scholar 

  6. Ezzat BA, Abbass MMS. The ability of H1 or H2 receptor antagonists or their combination in counteracting the glucocorticoid-induced alveolar bone loss in rats. J Oral Pathol Med 2014;43:148–56, doi:https://doi.org/10.1111/jop.12104.

    Article  CAS  Google Scholar 

  7. Biosse-Duplan M, Baroukh B, Dy M, de Vernejoul M-C, Saffar J-L. Histamine promotes osteoclastogenesis through the differential expression of histamine receptors on osteoclasts and osteoblasts. Am J Pathol 2009;174:1426–34, doi:https://doi.org/10.2353/ajpath.2009.080871.

    Article  CAS  Google Scholar 

  8. Williams GA, Longley RS, Bowser EN, Hargis GK, Kukreja SC, Vora NM, et al. Parathyroid hormone secretion in normal man and in primary hyperparathyroidism: role of histamine H2 receptors. J Clin Endocrinol Metab 1981;52:122–7.

    Article  CAS  Google Scholar 

  9. Wagner PK, Krause U, Scharfe T, Beyer J, Rothmund M. Effect of cimetidine on basal and histamine-induced secretion of parathyroid hormone in vitro. Nephron 1984;36:89–93.

    Article  CAS  Google Scholar 

  10. Solomon DH, Diem SJ, Ruppert K, Lian Yin J, Liu CC, Wohlfart A, et al. Bone mineral density changes among women initiating proton pump inhibitors or H2 receptor antagonists: a SWAN cohort study. J Bone Min Res 2015;30:232–9, doi:https://doi.org/10.1002/jbmr.2344.

    Article  CAS  Google Scholar 

  11. Corley DA, Kubo A, Zhao W, Quesenberry C. Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients. Gastroenterology 2010;139:93–101, doi:https://doi.org/10.1053/j.gastro.2010.03.055.

    Article  Google Scholar 

  12. Folwarczna J, Śliwiński L, Pytlik M, Janas A. Effects of histamine H1, H2 and H3 receptor antagonists on bone mechanical properties in female rats. Bone 2011;48:S193.

    Article  Google Scholar 

  13. Folwarczna J, Janas A, Pytlik M, Śliwiński L, Wiercigroch M, Brzęczek A. Modifications of histamine receptor signaling affect bone mechanical properties in rats. Pharmacol Rep 2014;66:93–9, doi:https://doi.org/10.1016/j.pharep.2013.08.010.

    Article  CAS  Google Scholar 

  14. Lesclous P, Guez D, Baroukh B, Vignery A, Saffar JL. Histamine participates in the early phase of trabecular bone loss in ovariectomized rats. Bone 2004;34:91–9, doi:https://doi.org/10.1016/j.bone.2003.08.007.

    Article  CAS  Google Scholar 

  15. Lesclous P, Schramm F, Gallina S, Baroukh B, Guez D, Saffar JL. Histamine mediates osteoclastic resorption only during the acute phase of bone loss in ovariectomized rats. Exp Physiol 2006;91:561–70, doi:https://doi.org/10.1113/expphysiol.2006.033217.

    Article  CAS  Google Scholar 

  16. Lesclous P, Guez D, Saffar JL. Short-term prevention of osteoclastic resorption and osteopenia in ovariectomized rats treated with the H2 receptor antagonist cimetidine. Bone 2002;30:131–6, doi:https://doi.org/10.1016/S8756-3282(01)00629-9.

    Article  CAS  Google Scholar 

  17. Dobigny C, Saffar JL. H1 and H2 histamine receptors modulate osteoclastic resorption by different pathways: evidence obtained by using receptor antagonists in a rat synchronized resorption model. J Cell Physiol 1997;173:10–8, doi:https://doi.org/10.1002/(SICI)1097-4652(199710)173:1<10:AID-JCP2>3.0.CO;2-M.

    Article  CAS  Google Scholar 

  18. Yamaura K, Yonekawa T, Nakamura T, Yano S, Ueno K. The histamine H-2-receptor antagonist, cimetidine, inhibits the articular osteopenia in rats with adjuvant-induced arthritis by suppressing the osteoclast differentiation induced by histamine. J Pharmacol Sci 2003;92:43–9.

    Article  CAS  Google Scholar 

  19. Longhini R, Aparecida de Oliveira P, Sasso-Cerri E, Cerri PS. Cimetidine reduces the alveolar bone loss in induced periodontitis in rat molars. J Periodontol 2016;2013:1115–25, doi:https://doi.org/10.1902/jop.2013.130453.

    Google Scholar 

  20. Kopic S, Geibel JP. Gastric acid, calcium absorption, and their impact on bone health. Physiol Rev 2013;93:189–268, doi:https://doi.org/10.1152/physrev.00015.2012.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, Wroclaw Medical University, Wrocław, Poland

    Agnieszka Matuszewska, Beata Nowak, Tomasz Sozański, Joanna Kwiatkowska, Małgorzata Pieśniewska & Adam Szeląg

  2. Department of Endocrinology, Diabetology and Isotopes Therapy, Wroclaw Medical University, Wrocław, Poland

    Diana Jędrzejuk, Marcin Landwójtowicz, Ewa Sadanowicz & Marek Bolanowski

Authors
  1. Agnieszka Matuszewska
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Beata Nowak
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Diana Jędrzejuk
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marcin Landwójtowicz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ewa Sadanowicz
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Tomasz Sozański
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Joanna Kwiatkowska
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Małgorzata Pieśniewska
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Marek Bolanowski
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Adam Szeląg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Beata Nowak.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Matuszewska, A., Nowak, B., Jędrzejuk, D. et al. Effect of long-term administration of ranitidine, a histamine H2 receptor antagonist, on bone metabolism in young growing rats. Pharmacol. Rep 70, 951–954 (2018). https://doi.org/10.1016/j.pharep.2018.03.005

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1016/j.pharep.2018.03.005

Keywords

Search

Navigation